GNH USA

Europe — EMA

Konverge

GNH USA supplies Konverge (Olmesartan medoxomil / amlodipine), a combined angiotensin II receptor blocker and calcium channel blocker for hypertension.

Olmesartan Medoxomil, Amlodipine

Request sourcing

1
Pack/s

What is Olmesartan Medoxomil, Amlodipine?

Olmesartan medoxomil, the active ingredient in Konverge, is an Angiotensin II receptor blocker presented as an oral tablet for oral use. It is combined with amlodipine, a calcium channel blocker, to treat hypertension in adult patients.

GNH USA supplies Konverge as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Olmesartan Medoxomil, Amlodipine used for?

Konverge is indicated for the management of high blood pressure, acting on the renin‑angiotensin system and vascular smooth muscle tone.

Hypertension: lowers systolic and diastolic pressure to reduce cardiovascular risk.

What are the side effects of Olmesartan Medoxomil, Amlodipine?

Common Side Effects: - Dizziness - Headache - Peripheral edema - Flushing - Fatigue - Nausea

Serious or Rare Side Effects: - Angioedema - Severe hypotension - Elevated liver enzymes - Myocardial infarction - Acute renal impairment - Allergic reactions such as rash or bronchospasm

What precautions apply to Olmesartan Medoxomil, Amlodipine?

Before initiating therapy, consider the following precautions: - Monitor blood pressure regularly: ensure target levels are achieved without excessive drop. - Assess renal function: adjust therapy if creatinine clearance is reduced. - Review electrolyte balance: watch for hyperkalemia when combined with potassium‑sparing agents. - Avoid use in severe hepatic impairment: limited data on safety. - Use with caution in elderly patients: increased sensitivity to hypotensive effects. - Store at ambient temperature: keep in original container, protect from moisture.

What does Olmesartan Medoxomil, Amlodipine interact with?

Konverge may interact with several drug classes. Review the following:

Major Interactions (Avoid): - Aliskiren: concurrent use can cause excessive renin‑angiotensin blockade. - Potassium‑sparing diuretics: risk of hyperkalemia. - NSAIDs: may attenuate antihypertensive efficacy and affect renal function.

Moderate Interactions (Monitor Closely): - CYP3A4 inhibitors (e.g., erythromycin, clarithromycin): may increase amlodipine levels. - CYP3A4 inducers (e.g., rifampin, carbamazepine): may reduce amlodipine exposure. - Other antihypertensives: additive blood pressure‑lowering effect, requiring dose adjustment.

Frequently asked questions

What is Konverge used for?+
Konverge is a prescription medication that combines olmesartan medoxomil and amlodipine to treat hypertension. By targeting two complementary pathways that control vascular tone, it helps lower elevated blood pressure and reduces the risk of cardiovascular complications in adult patients.
How does olmesartan medoxomil work?+
Olmesartan medoxomil blocks the angiotensin II type 1 (AT1) receptor, preventing the hormone angiotensin II from causing vasoconstriction and stimulating aldosterone release. This results in relaxed blood vessels, reduced fluid retention, and ultimately lower blood pressure.
What is the usual dose of Konverge?+
The dosage of Konverge is determined by the prescribing clinician based on the patient’s blood pressure, response to therapy, and overall health status. The prescriber will select the appropriate strength and dosing schedule for each individual.
Is Konverge safe during pregnancy or breastfeeding?+
The safety of Konverge in pregnancy or while nursing has not been established. It should be used only if the potential benefit justifies the potential risk to the fetus or infant, and decisions should be made in consultation with a healthcare professional.
How do I order Konverge from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.
How does Konverge compare with other antihypertensive options?+
Konverge offers a dual‑mechanism approach by combining an angiotensin II receptor blocker with a calcium channel blocker, which can provide more consistent blood pressure control than monotherapy. Compared with separate tablets, the fixed‑dose combination may improve adherence and simplify treatment regimens.
What are the storage requirements for Konverge?+
Konverge should be stored at ambient temperature, below 25 °C. Keep the tablets in the original packaging, protect them from moisture and direct sunlight, and ensure the container is tightly closed to maintain product stability.
How is Konverge administered?+
Konverge is taken orally, usually once daily, with or without food. Swallow the tablet whole with a glass of water. Patients should follow the dosing instructions provided by their prescriber and not alter the regimen without medical advice.
What are the most serious risks associated with Konverge?+
Serious adverse events, although rare, can include angioedema, severe hypotension, acute renal impairment, and significant liver enzyme elevations. Patients should seek immediate medical attention if they experience swelling of the face or throat, dizziness, fainting, or signs of liver dysfunction.
Who should not use Konverge?+
Konverge is contraindicated in patients with known hypersensitivity to olmesartan, amlodipine, or any component of the formulation. It should also be avoided in individuals with severe hepatic impairment and in those taking aliskiren concomitantly if they have diabetes or renal impairment.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Olmesartan Medoxomil, Amlodipine
Route
Oral Use
Manufacturer
Menarini International Operations Luxembourg S.A.
Origin
EU

Related products